Contact us   |  

Departments

Information

Department

About the department

Department name (English): Hematology

Department name (original): Hematologie

Subnetworks of expertise:

  • Myeloid malignancies
  • Bleeding - Coagulation disorders
  • Hemochromatosis and other iron disorders
  • Bone marrow failure

Healthcare provider: Radboud University Medical Center Nijmegen

Diseases covered by the department:

  • Tumor of hematopoietic and lymphoid tissues
  • Mastocytosis
  • Systemic mastocytosis
  • Myeloid hemopathy
  • Acute myeloid leukemia
  • Myelodysplastic syndrome
  • Myeloproliferative neoplasm
  • Polycythemia vera
  • Myelodysplastic/myeloproliferative disease
  • Myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1
  • Polycythemia
  • Primary familial polycythemia
  • Secondary polycythemia
  • Congenital secondary polycythemia
  • Acquired secondary polycythemia
  • Rare coagulation disorder
  • Rare thrombotic disease of hematologic origin
  • Rare hemorrhagic disorder
  • Rare hemorrhagic disorder due to a coagulation factors defect
  • Rare hemorrhagic disorder due to a constitutional coagulation factors defect
  • Hemophilia
  • Hemophilia A
  • Severe hemophilia A
  • Moderately severe hemophilia A
  • Mild hemophilia A
  • Symptomatic form of hemophilia A in female carriers
  • Hemophilia B
  • Severe hemophilia B
  • Moderately severe hemophilia B
  • Mild hemophilia B
  • Symptomatic form of hemophilia B in female carriers
  • Congenital factor V deficiency
  • Congenital fibrinogen deficiency
  • Familial afibrinogenemia
  • Familial dysfibrinogenemia
  • Familial hypofibrinogenemia
  • Familial hypodysfibrinogenemia
  • Congenital alpha2-antiplasmin deficiency
  • Congenital factor XIII deficiency
  • Von Willebrand disease
  • Von Willebrand disease type 1
  • Von Willebrand disease type 2
  • Von Willebrand disease type 2A
  • Von Willebrand disease type 2B
  • Von Willebrand disease type 2M
  • Von Willebrand disease type 2N
  • Von Willebrand disease type 3
  • Congenital factor XI deficiency
  • Congenital plasminogen activator inhibitor type 1 deficiency
  • Combined deficiency of factor V and factor VIII
  • Rare hemorrhagic disorder due to an acquired coagulation factor defect
  • Acquired prothrombin deficiency
  • Acquired hemophilia
  • Acquired von Willebrand syndrome
  • Rare hemorrhagic disorder due to a platelet anomaly
  • Rare hemorrhagic disorder due to a constitutional platelet anomaly
  • Rare hemorrhagic disorder due to a qualitative platelet defect
  • Glanzmann thrombasthenia
  • Scott syndrome
  • P2Y12 defect
  • Pseudo-von Willebrand disease
  • Rare hemorrhagic disorder due to an acquired platelet anomaly
  • Autoimmune thrombocytopenia
  • Immune thrombocytopenic purpura
  • Rare anemia
  • Sideroblastic anemia
  • Constitutional sideroblastic anemia
  • X-linked sideroblastic anemia
  • Autosomal recessive sideroblastic anemia
  • Rare hemolytic anemia
  • Rare constitutional hemolytic anemia
  • Rare acquired hemolytic anemia
  • Aplastic anemia
  • Rare constitutional aplastic anemia
  • Rare acquired aplastic anemia
  • Rare deficiency anemia
  • Rare acquired deficiency anemia
  • Constitutional dyserythropoietic anemia
  • Congenital dyserythropoietic anemia
  • Rare iron overload

Service offered

  • Prevention and genetic counseling
  • Diagnostics
  • Treatment and care

Patients covered

  • Adults
  • Ageing

Health professionals

Name Surname Academic title Charge